TurboRegs is a cloud based, SaaS e-regulatory automation solution built to work, like you work:
- SSO Integration
- CTMS and TMF Solution Interoperability
- IRB APIRequest a Demo
Focused on speed, accuracy and consistency, TurboRegs allows users to create new entries which are stored in a drop down menu for future use.
Ever wonder where you are in the study start-up process? PharmaHuddle™ allows for the study team of each protocol, instant message access to start up contributors at the site/sponsor/CRO.
Add sites individually or upload a bulk list of sites for immediate invite to a study. Track your sites’ progress through the start up workflow and ensure that milestones are met.
Leverage patent pending algorithms to confirm compliance of investigators throughout the life of your study.
Use the proprietary PDF Review module embedded within TurboRegs™ to review and approve documents between sponsor and sites prior to finalization and submission.
Effective as of Sep 1, 2019
Welcome to the TurboRegsTM service, a collaborative regulatory document tool to facilitate and expedite processing between sponsor or sponsor delegate and investigative site. The following terms and conditions of use (together with any documents referred to herein, the “ Agreement”) apply to your use of the TurboRegs application located at www.turboregs.com (“TurboRegs”). You must acknowledge you have read and agree to the terms and conditions of this Agreement prior to creating an account with TurboRegs. If you do not agree to the terms and conditions of this Agreement, you may NOT use TurboRegs.
TurboRegs may modify or amend this Agreement at any time at our sole discretion. Changes will be communicated to you by posting a new version of the Agreement on the TurboRegs website at www.turboregs.com/terms or as otherwise determined by us in our sole discretion. Your continued use of TurboRegs after such notification of changes to this Agreement will constitute your acceptance of such changes. You may also be asked to re-acknowledge and reaccept this Agreement following certain material changes.
Subject to your compliance with the terms and conditions of this Agreement, you are granted a limited, non-exclusive, non-transferrable, and revocable license to make use of TurboRegs. You do not have a right to transfer or sublicense your rights under this Agreement. Third party components included in TurboRegs are licensed to you either under this Agreement or under the relevant third party component license terms, as applicable. In addition, certain open-source software included in TurboRegs is licensed to you pursuant to applicable open-source licenses. Your use of the licenses described herein is subject to the restrictions set forth in Section 9 below. Sharma Consulting reserves all rights not expressly granted herein.
You agree that you will not upload or submit any information that you do not have the legal right to upload or submit, including without limitation Sensitive Information that contains third-party copyrighted material used without permission or Sensitive Information that violates other third-party proprietary rights.
Content displayed on TurboRegs’ website (including, but not limited to, original works of authorship, text, graphics, logos, button icons, images, audio clips, data compilations, and software, and the compilation thereof) is the exclusive property of Sharma Consulting, our affiliates, our partners or our licensors, and is protected by patents, trademarks, service marks, copyrights, trade secrets or other intellectual property rights and laws, as applicable. You agree to abide by and maintain all copyright and trademark notices, information, and restrictions contained in any content accessed through TurboRegs.
The trademarks, logos, slogans, and service marks displayed on the TurboRegs website (collectively, the “Trademarks”) are the registered or unregistered marks of Sharma Consulting, our affiliates, our licensors or our partners, in the United States and other countries, and are protected by United States and international trademark laws. All other trademarks not owned by us, our affiliates, our partners or our licensors that appear on TurboRegs are the property of their respective owners, who may or may not be affiliated with or connected to Sharma Consulting. Except as set forth herein, or as required or permitted under applicable law, no portion of the TurboRegs website may be used, reproduced, duplicated, copied, sold, resold, accessed, modified, or otherwise exploited, in full or in part, for any purpose without our prior written consent.
By establishing an account with us, you grant permission for TurboRegs to contact you at your e-mail address. To stop receiving our marketing emails, send an E-mail to us at support@TurboRegs.com or follow the opt-out procedures set forth in such marketing emails. Please note that TurboRegs will still need to communicate with you via email regarding your transactions and other account related issues, and that these emails are not marketing emails and are not eliminated through the foregoing opt-out procedures.
You hereby agree to that TurboRegs provides the site as a location for you to execute the documents relating to the Regulatory Packet. When you execute your documents through TurboRegs, only you have rights and duties with respect to such documents. TurboRegs is not a party to any agreement, and shall not have any liability or responsibility whatsoever with respect to the validity or enforceability of any documents. The sole customer support function provided by TurboRegs is to answer questions regarding the functions of the site.
By delivering to TurboRegs copies of documents, you are authorizing TurboRegs to imprint thereon your signature and to distribute the executed version of such documents to the appropriate party. TurboRegs will not make any other use of such documents without your prior written authorization.
By signing documents on TurboRegs, you are consenting to electronic signatures. You are not required to use TurboRegs to execute documents. To withdraw your consent to electronic transactions and electronic signatures, stop using TurboRegs or print and sign your documents manually. Any decision to consent or not consent to current or future document execution does not have an effect on the legality of documents previously executed on TurboRegs.
ANY STATEMENTS MADE BY TURBOREGS ABOUT THE VALIDITY OF ELECTRONIC SIGNATURES ARE GENERAL IN NATURE AND ARE NOT INTENDED, AND SHOULD NOT BE CONSTRUED, AS LEGAL ADVICE. TURBOREGS HEREBY DISCLAIMS ANY RESPONSIBILITY FOR ENSURING THAT DOCUMENTS ELECTRONICALLY EXECUTED THROUGH TURBOREGS ARE VALID OR ENFORCEABLE UNDER THE LAWS OF ANY PARTICULAR STATE OR OTHER JURISDICTION. IF YOU WISH TO VERIFY THE VALIDITY OR ENFORCEABILITY OF ELECTRONIC SIGNATURES YOU SHOULD CONSULT A LICENSED ATTORNEY FOR APPROPRIATE LEGAL ADVICE.
You may use TurboRegs only for lawful purposes and in accordance with this Agreement. You are responsible for all of your activity in connection with TurboRegs. Any unauthorized use of TurboRegs by you or anyone under your control terminates the limited license set forth in Section 4 above, without prejudice to any other rights and remedies provided herein. For the avoidance of doubt, you agree that you may not (without limitation):
TurboRegs maintains an audit trail of all information processed through the application. An audit trail is a chronological record of the sequence of actions and events that occur within the application, and in particular within a specific Regulatory Packet. Audit trails include, among other things, recordation of creations, modifications and deletions, automatic time stamps, identification and prevention of modification. Audit trails are automatically added every time an action is taken within the application and cannot be modified.
As consideration for your rights under this Agreement, you agree that Sharma Consulting has a right to allow TurboRegs to utilize the processor, bandwidth and storage hardware on your computer or other relevant device for the limited purpose of facilitating the communication and transmission of data to you and other TurboRegs users, and to facilitate the operation of the network on which TurboRegs runs. You are referred to the settings of your device for additional information relating to device performance in connection with your use of TurboRegs.
Your use of TurboRegs is at your sole risk. The services provided by TurboRegs are provided on an “as is” and “as available” basis. To the fullest extent possible under applicable law, Sharma Consulting disclaims and gives no warranty, express or implied, including without limitation any warranty as to the quality, accuracy and availability or fitness for a specific purpose of TurboRegs or warranty of title or non-infringement.
Sharma Consulting does not warrant that: (i) the service will meet your specific requirements; (ii) the service will be uninterrupted, timely, secure, or error-free; (iii) the results that may be obtained from the use of the service will be accurate or reliable; (iv) the quality of any products, services, information, or other material obtained by you through the service will meet your expectations; OR (v) any errors in the service will be corrected.
You agree that Sharma Consulting will not be responsible, under any circumstances, for: (a) inability to use TurboRegs; (b) loss of profits; (c) business interruption; (d) corruption of files; (e) loss of business information; (f) loss of data; (g) service interruption; (h) computer viruses or device failure; (i) pecuniary loss; (j) unauthorized access to or alteration of your transmissions or data; (k) statements or conduct of any third party; (l) loss of communication between TurboRegs and any third party multimedia; or (m) any other events beyond our control.
FURTHER, TO THE MAXIMUM EXTENT PERMITTED BY LAW SHARMA CONSULTING WILL NOT BE LIABLE FOR ANY INDIRECT, SPECIAL, INCIDENTAL, OR CONSEQUENTIAL DAMAGES OF ANY KIND (INCLUDING LOST PROFITS) RELATED TO TURBOREGS REGARDLESS OF THE FORM OF ACTION WHETHER IN CONTRACT, TORT (INCLUDING NEGLIGENCE), OR OTHERWISE, EVEN IF WE HAVE BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. IN NO EVENT SHALL OUR MAXIMUM AGGREGATE LIABILITY EXCEED ONE HUNDRED DOLLARS ($100).
You agree to defend, indemnify and hold harmless Sharma Consulting, its affiliates and licensors and their respective officers, directors, employees, contractors, agents, licensors and suppliers from and against any claims, liabilities, damages, judgments, awards, losses, costs, expenses or fees (including but not limited to reasonable attorneys’ fees) resulting from your violation of any laws or regulations, this Agreement, or your use of TurboRegs.
Sharma Consulting will make reasonable efforts to keep TurboRegs operational. However, certain technical difficulties or maintenance may, from time to time, result in temporary interruptions. Sharma Consulting reserves the right at any time and from time to time to modify or discontinue, temporarily or permanently, functions and features of TurboRegs with or without notice.
With respect to any dispute regarding TurboRegs or this Agreement, your rights and obligations and all actions contemplated by this Agreement shall be governed by the laws of the State of New York, as if the Agreement were a contract wholly entered into and wholly performed within New York. Any dispute relating in any way to TurboRegs shall be submitted to confidential arbitration in New York, except that, to the extent you have in any manner violated or threatened to violate our intellectual property rights, we may seek injunctive or other appropriate relief in New York, and you consent to exclusive jurisdiction and venue in such courts. Arbitration under this agreement shall be conducted under the rules then prevailing of the American Arbitration Association. The arbitrator’s award shall be binding and may be entered as a judgment in any court of competent jurisdiction. To the fullest extent permitted by applicable law, no arbitration under this Agreement shall be joined to an arbitration involving any other party subject to this Agreement, whether through class arbitration proceedings or otherwise.
Neither this Agreement nor any content, materials or features of TurboRegs create any partnership, joint venture, employment, or other agency relationship between you and Sharma Consulting. You may not enter into any contract on our behalf or bind us in any manner.
Sharma Consulting may assign this Agreement or any part of it without restrictions. You may not assign this Agreement or any part of it to any third party.
Should any provision of this Agreement be held invalid or unenforceable, for any reason or to any extent, such invalidity or enforceability shall not in any manner affect or render invalid or unenforceable the remaining provisions of this Agreement and TurboRegs shall be enforced to the extent permitted by law.
If you have any questions concerning TurboRegs or this Agreement, please let us know by sending an E-mail to firstname.lastname@example.org.
Copyright © 2019 Sharma Consulting LLC. All rights reserved.
Sharma Consulting LLC, 102 Christopher Columbus Dr., Apt 909, Jersey City, NJ 07302
Effective as of Sep 1, 2019
A. User Information. When you create a TurboRegs account is created for you, we will request and you will provide us with certain information such as your name, discipline, contact names, postal addresses, phone numbers, E-mail addresses, and the URL from which you are signing into TurboRegs.
B. Regulatory Packet. Further Use of TurboRegs requires you or your sponsor to electronically submit a suite of forms (the “Regulatory Packet”), which will be used to produce and complete a Statement of Investigator Form FDA 1572 to comply with 21 CFR 312.53(c). The Regulatory Packet includes, among other forms, curriculum vitae of listed personnel, medical licenses of listed personnel, financial disclosures in sponsor by listed personnel, IRB Membership list or DHHS number, local lab normal range, local lab certification, and local lab director curriculum vitae.
Necessarily, the Regulatory Packet will include sensitive personal, professional, financial and other data typically provided in Form FDA 1572 (the “Sensitive Information”). All Sensitive Information will be uploaded to TurboRegs’ servers for access by you or your sponsor and shall be stored and/or backed-up on TurboRegs’ secure servers or on servers of trusted third parties as necessary, and in accordance with TurboRegs’ then-current storage practices.
We will not share Sensitive Information with others without your permission. We are working to offer the ability to export data and other information from your account to a readable format at any time during or after the Term of this Agreement.
C. Automatic Collection. In addition, when you use TurboRegs, we will automatically receive information relating to your use of TurboRegs, including all data inputted into TurboRegs’ fields, all inputted and uploaded Sensitive Information (as defined in Section 1.B above), your internet protocol address, data relating to performance of your network and computer or device, language and identifying information, and your operating system.
D. Cookies. We may also store information about you using cookies (files which are sent by us to your computer or other access device) that we can access when you visit TurboRegs. We do this to help improve the user experience of TurboRegs. If you want to delete any cookies that are already on your computer or device, please refer to the instructions for your file management software to locate the file or directory that stores cookies. Please note that by deleting our cookies or disabling future cookies you may not be able to access certain areas or features of TurboRegs.
E. Additional. We may also, from time to time, collect information from you through surveys in which you may choose to participate.
Unless you give us your explicit approval and except as outlined in Section 1 above, we will only share your information as is necessary to:
a. Enforce the TurboRegs Terms and Conditions of Use.
b. Comply with laws, regulations and any applicable court orders or to respond to requests from governmental or administrative bodies or to comply with litigation matters or other legal process, and/or to establish or exercise our legal rights or defend against legal claims.
d. Allow us to use a third party to perform surveys measuring your experiences and use of TurboRegs (not permitting the third party to use your Sensitive Information for any other purpose).
e. Allow us to share aggregated statistics and information with parties with whom we do business.
We know the value of your information, and we take security extremely seriously. We take a number of steps to keep your information secure from unauthorized access. For example, we ask you to use a unique and strong password and not to share this information with anyone. In addition, we use secure encryption with open SSL and x509 certificates to limit access to the systems that store your personal information. Further, we respect and comply with applicable laws and regulations on data protection. Additionally TurboRegs makes every reasonable effort to maintain compliance with the requirements of 21 CFR Part 11, including but not limited to, the internal security and audit trail requirements thereof, as discussed in more detail in Section 10 of the TurboRegs Terms and Conditions of Use.
You are responsible for maintaining the security of your user access name and related password. While we work extremely hard to safeguard your information once we receive it, please be aware that no transmission of data over a public network or storage of data on a cloud network can be guaranteed to be 100% secure.
You can access and update by sending a request to email@example.com. We will endeavor to respond to your request upon verification of your identity within a reasonable period of time, and to the maximum extent practical.
Subject to Section 7 of the TurboRegs Terms and Conditions of Use, you may opt out of receiving future E-mail communications from us by E-mailing us at firstname.lastname@example.org.
Copyright © 2019 Sharma Consulting LLC. All rights reserved.
Sharma Consulting LLC, 102 Christopher Columbus Dr. Apt 909, Jersey City, NJ 07302
(Effective as of 01 Sep 2019)
You are receiving this information because you are a Principal Investigator (study team),affiliated within the European Economic Area("EEA"),currently engaged in a clinical trial supported by TurboRegs™.Therefore,the EU General Data Protection Regulation(GDPR) will apply to the collection of trial data performed as part of this clinical trial. The purpose of this communicationis to clarify how GDPR applies to clinical research,and to request your collaboration in executing the actions described below.
The GDPR replaces the current Data Protection Directive 95/46/EC as of 25th May,2018. It was designed to harmonize data privacy laws across Europe, to strengthen the privacy rights of EU residents,and to reshape the way organizations across the region approach data privacy protection.
You as Principal Investigator (study team), as well as your institution, and we,as Supporters of this clinical trial,have committed in our mutual Clinical Trial Agreement to comply with applicable data protection laws. In particular,when processing Personal Information 1 of your investigation staff and of trial subjects,that data should be protected in accordance with applicable laws and regulations, including the GDPR.
The information in this document is intended for you,as Principal Investigator and for your investigational staff.It is not to be provided to trial subjects, although it provides guidance to you and your investigational staff on how to respond to questions from trial subjects.
Action to be performed by the Principal Investigator
Collection of Personal Information concerning Principal Investigator and investigational staff
Read the privacy notice for Principal Investigator and investigational staff. See appendix 2.
Provide a copy of the privacy notice for Principal Investigator and investigational staff to the investigational staff members engaged in the research.
concerning the additional responsibilities under
Read the section about additional responsibilities under GDPR, and
the Frequently Asked Questions(FAQ)in appendix 1.
1 Personal Information(a/k/a"personal data") is defined as any information relating to an identifiable person who can be directly or indirectly identified in particular by reference to an identifier such as a name, an identification number,location data,an online identifier or to one or more factors specific to the physical, physiological, genetic, mental, economic,cultural or social identity of that natural person.
Action to be performed by the Principal Investigator
Increase awareness concerning the additional responsibilities under GDPR
Inform any investigational staff appropriately about the new obligations under GDPR.In particular it is important that there is a general awareness of what to do incase an individual who participates in the clinical trial(“Trial Subject”)makes a request concerning the processing of his/her data,or needs to be informed of an accidental or unlawful destruction, loss, alteration, unauthorized disclosure of,or access to, Personal Information data transmitted, stored or otherwise processed(“Privacy Incident”).
Personal Information concerning trial subjects (Not Applicable in capacity of TurboRegs™)
If requested by the Supporter(or CRO),execute activities to inform trial subjects as instructed.Use the NoticeLog, inAppendix 4,to document providing the Notice to trial subjects.
Personal Information concerning Trial Subjects (Not Applicable in capacity of TurboRegs™)
Incase of questions from trial subjects concerning the irdata, please action accordance with the Frequently Asked Questions(FAQ) in Appendix 1.
Once you have completed action 1,2 and 3 above,and acknowledged your commitment to address action 4 and 5 as may be requested,please click Acknowledge button as understanding, verification and acceptance.See Appendix 3.
One of the core building blocks of GDPR's enhanced rights for individuals is the requirement for greater transparency with respect to the purpose and use of the personal data collected about them.Information must be provided to data subjects in a concise,transparent,and easily accessible form,using clear and plain language.The Supporter has developed the following process to address this requirement.
Providing Trial Subjects (if applicable)with additional information as required under GDPR:
The Supporter/CRO will provide the Clinical Site with a Notice of Privacy Rights for Clinical Trial Participants With few exceptions,the Principal Investigator or his/her investigational staff must provide a physical copy of this Notice to Trial Subjects that are currently engaged in the Trial.Typically,this is done at the next time the trial subject is visiting the clinical site
Once the trial subject receives the Notice, this is documented using the Notice Log. See Appendix 4.See Appendix 1–Frequently Asked Questions.
Providing investigational staff with additional information as required under GDPR:
Provide a copy of the Privacy Notice towards Principal Investigator and investigational staff to all current staff members.See appendix 2.
Data Subject Rights (If applicable)
GDPR provides data subjects within the European Economic Area(EEA) with expanded rights intended to strengthen and enhance the data subjects’ abilities to control how their personal information is processed. However,it should be recognized that the applicability of these rights depends on the legal basis for the processing,as well as limitations that may be introduced by other laws.See Appendix 1 – Frequently Asked Questions for more information on how to address data subject right request from Trial Subjects.
Incase of a Data Breach/Privacy Incident2
GDPR is introducing a mandatory data breach notification requirement as specified in GDPR article 33.We recognize that this Data Breach notification requirement may apply to the Supporter, third parties performing activities on behalf of the Supporter, as well as the Principal Investigator or Institution, depending on the nature of the data breach and the data that is impacted.Consequently, we would appreciate your timely notification to use of any Privacy Incident that may result in a breach.See Appendix 1 – Frequently Asked Questions for information on how to handle a Privacy Incident.
Data Protection Impact Assessments
GDPR introduced a requirement to perform a data protection impact assessment(DPIA) for certain types of processing activities, for example, when processing Personal Information using new technologies. The DPIA should also take into account the nature,scope,context and purposes of the processing.,In the event the data protection impact assessment indicates that the processing would result in a high risk,in the absence of measures taken by the controller to mitigate the risk,the supervisory authority should be consulted before the processing of Personal Information. See appendix 1–Frequently Asked Questions on how this requirement may apply to an ongoing Clinical Trial.
2 A breach of security leading to the accidental or unlawful destruction, loss, alteration,unauthorized disclosure of,or access to,Personal Information data transmitted, stored or other wise processed.
A. Data Subject Rights(N/A for current use case of TurboRegs™)
What do I do if a Trial Subject asks for access to his/her coded information,which has been provided to the Supporter?
The right to access may apply, but may be limited while the study is ongoing, providing access to data may not be permitted,considering regulations and laws that apply to clinical research.E.g.some data may not be provided until after the study is completed. You may reach out to the Project Manager for guidance and support as may be required.
What should I do if a Trial Subject requests a copy of their Personal Information(including any coded data)in a commonly used electronic format?
The right to portability is dependent on the legal basis for the processing of data. We recognize that this right may apply, depending on the local position of the data protection authority. If this right applies, the right is limited in that all in formation cannot be provided until the trial is completed, due to regulatory requirements that apply in Clinical Research.You may contact the Project Manager for guidance and support as may be necessary.
What should I do if a Trial Subject requests that his/her data be corrected?
Any correction of data should be done in accordance with Good Clinical Practice3 on how changes to clinical data should be carried out.The standard processes how to manage data changes at the Clinical Site should be applied.In case of questions you may contact the Project Manager for additional guidance. 3 See ICH GUIDELINE FOR GOOD CLINICAL PRACTICE E6(R1)Section4.9.3.
What should I do if a Trial Subject asks that his/her data(including any coded data) to be deleted?
Data that is collected and processed per the Clinical Study Protocol cannot be deleted due to laws and regulations that apply in clinical research. For situations where Personal Information of the Trial Subject is processed and such processing is not required by the clinical study protocol,the deletion right may apply and should be assessed on a case by case basis.Please contact Supporter/CRO in such situations.
What should I do if a Trial Subject objects to the processing of his/her Personal Information?
A Trial Subject may have the right to object to certain processing of his/her data.
If a Trial Subject objects to all processing of his/her data,it may be required that he/she withdraw from participating in the trial,since the processing of some personal data is a critical part of any trial.
Any objection from a Trial Subject should be forwarded to the Project Manager,to ensure that the Supporter can appropriately evaluate such an objection and provide guidance to the site.
What do I do if a Trial Subject would like to get a copy of the safeguards that the Supporter is using for any transfer of the coded data to parties based outside of the European Economic Area?
Contact the Project Manager.The Project Manager may need to engage the Supporter’s Data Protection Officer to respond to the request.
B. Privacy Notice/Informed Consent(N/A for current use case of TurboRegs™)
I understand that the Trial Subject may have the right to receive additional information about the processing of their Personal Information(including any coded data).How will this be managed?
The Supporter has developed a Notice of Privacy Rights for Clinical Trial Participants document that must be provided to all Trial Subjects,as described in the section about "Providing Trial Subjects with additional information as required under GDPR" above.
Further guidance may be provided by the Project Manager considering that the situation may be different per country,and there is a dependency with the local ethic committees and the position of the local data protection authority.
Will Trial Subjects need to sign this Notice of Privacy Rights for Clinical Trial Participants?
No, the Trial Subject does not need to sign the Notice.However,when the Trial Subject is provided the Notice of Privacy Rights for Clinical Trial Participants,it must be documented using the Notice Log.See Appendix 4.
Do I need to provide this Notice of Privacy Rights for Clinical Trial Participants to Trial Subjects that have completed their last visit,and there is no additional data that will be collected from the Trial Subject?
No; however,you must use the Notice Log, in Appendix 4 to document that the Trial Subject will not receive the Notice of Privacy Rights for Clinical Trial Participants because he/she has completed the trial.
How do I handle Trial Subjects who will not have any more visits,but where additional data will be collected e.g.via phone or similar?
The Notice of Privacy Rights for Clinical Trial Participants should be sent by mail to the Trial Subject. This must be documented in the Notice Log. See Appendix 4.
Will Trial Subjects need to sign a new Informed Consent Form due to GDPR?
We do not believe this will be required.Rather, Trial Subjects will be provided with a Notice of Privacy Rights for Clinical Trial Participants that will inform them of their rights under GDPR.However, we recognize that the situation may be different from country to country,and there is a dependency with the local ethic committees and the position of the local data protection authority. Further guidance may be provided by the Project Manager. C.Other
What is the legal basis for the processing of Personal Information about Trial Subjects?
On16th of April2018,he Article29 Working Party 4 issued a guidance on consent (wp259rev.01),in which it was stated that the consent obtained in clinical research from Trial Subjects is not necessarily the legal basis for processing their Personal Information.
The Supporter’s position is that processing of Personal Information concerning Trial Subjects is based on the regulations and laws that apply to clinical research.Such regulations require the study site to collect and the Supporter to analyze such data before they are submitted to regulatory authorities.In addition,the legal basis can be the performance of the scientific research that is referenced in the consent form signed by the Trial Subject.
There are other legal grounds that may apply as well in certain situations,such as that the processing is required for the vital interest of the subject e.g.in case of a significant patient safety concern,or due to a public interest in the area of public health.
We recognize that there are still discussions about this topic with in the industry and realize that the local positions may potentially differ. 4 The article29 working party is an advisory body made up of a representative from the data protection authority of each EU Member State,the European Data Protection Supervisor and the European Commission.
What do I do in case of a Privacy Incident?
For any privacy incident that relates to data where the owner is the Supporter as defined in the Clinical Trial Agreement,you should immediately inform the Project Manager.The information to the Project Manager should include the nature of the privacy incident,the categories and approximate number of Trial Subjects whose data was compromised,and Personal Information records impacted by such privacy incident.We request you as Principal Investigator and the Institution to fully cooperate with the Supporter,to investigate and resolve any such privacy incident and provide Supporter any information necessary to provide notifications to the impacted Trial Subjects.
Incase a privacy incident relates to a system,or processing activity under the sole control of the Institution,the Institution will be responsible for managing such Incident.However,you should also inform the Project Manager incase any source data that may relate to the Clinical Trial may be impacted in such a privacy incident.
Is there a need to do a Data Protection Impact Assessment,and will the Clinical Site need to be engaged in such an activity?
The Data Protection Impact Assessment requirement does not apply retrospectively,so it is not likely that the Clinical Site will need to support such an effort for any processing of Personal Information under the Clinical Trial Agreement.However,incase new technology, such as a wearable device collecting health data,is introduced in an ongoing trial, such change may require a Data Protection Impact Assessment.You will be requested by the Supporter incase there is a need for the Clinical Site to support the execution of any Data Protection Impact Assessment.
Who is the data controller and for what kind of data?
The Supporter is a data controller for any processing the data that is provided to the Supporter,and that may be specifically processed as instructed by the Supporter using tools that is provided by the Supporter to perform the research.
The Clinical Site is a data controller for data processing activities under the sole responsibility of the site such as entering of data in the Electronic Medical Record System,and processing data for the care of the patient.
The Clinical Site may be seen as a data processor for processing activities that is specifically executed as required by the Study Protocols instructed by the Supporter using tools provided by the Supporter.Entering key‐coded data in the eCRF would be an activity,where the Clinical Site is acting as a data processor.
This Notice explains the personal information handling practices of Supporter with respect to information about the Principal Investigator and any investigational staff.It explain show Supporter collects personal information,and with whom Supporter may share it.It also explains the rights the Principal Investigator and any investigational staff have with regard to this personal information.This Notice applies to all personal information,regardless of whether the information is stored electronically or in hard copy.
This Privacy Notice should be provided by the Principal Investigator to any investigational staff.
Personal Information Collection
Supporter and agents processing personal information on behalf of Supporter,collect and process personal information about you.This information may come directly from you,from the Institution that you are affiliated with for purposes of this clinical research,or from public or third‐party information sources.
The types of personal information that Supporter collects depends on the role you have with Supporter and/or its affiliates,as well as applicable laws,and may include the following categories of information:
Contact information(e.g.address,telephone number,e‐mail address);
Age and/or date of birth;
Government identification number(if applicable);
Training and qualifications,including information that you have a valid,active medical or professional license,as applicable,and are not debarred by a competent health authority;
Organizational or institutional affiliations;
Professional programs and activities in which you may have participated;
Financial information relating to,among other matters,compensation and reimbursement payments for clinical trial activities;
Engagement or interaction with Supporter or its affiliates,or their products and services;
Information obtained via survey sand other direct interactions with you.
How Supporter Uses and Discloses Personal Information
Personal information about you will be processed for the following purposes to meet Supporter’sand/or its affiliates’ obligations under applicable laws and regulations, and as necessary to fulfill the Clinical Trial Agreement:
To assess if you are suitable for acting as Principal Investigator or investigational staff in relation to the clinical trial;
To provide training,and access to tools and other resources that may be required for the execution of the clinical trial;
To manage the clinical trial, including to monitor and audit clinical trial activities;
To prepare and submit regulatory filings,correspondence,and communications to government authorities concerning the clinical trial;
To conduct safety reporting and pharmacovigilance activities relating to the clinical trial;
To publish results of the clinical trial as defined in the Clinical Trial Agreement;
investigational staff in order to comply with transparency reporting laws,including but not limited to the US Physician Payments Sunshine Act and implementing regulations,as well as industry codes of practice or standards to which Supporter and/or Supporter’s affiliates are subjector
As other wise required under applicable law,or necessary to fulfill the Clinical Trial Agreement.
Personal information about you will be processed for the following purposes based on Supporter’ sand its affiliates’ legitimate interest under law:
To consider,from time to time,potential sites and investigators for future clinical trials;and To conduct surveys,manage internal studies,improve processes and practices related to the execution of clinical trials and other activities related to medical research.
To accomplish the above mentioned purposes,personal information is made available to:
Other affiliates of the TurboRegs Family of Companies and the irrespective agents.;
Government Authorities and ethics committees in jurisdictions around the world;
Agents,such as contract research organizations or other third‐party service providers,processing Personal Information on behalf of Supporter.
Cross Border Transfer
Your personal information may be stored and processed in any country where Supporter and its affiliates have facilities or agents, including the United States. Some non‐European Economic Area (EEA) countries are recognized by the European Commission as providing an adequate level of data protection according to EEA standards (the full list of these countries is available here:https://www.littler.com/gdpr/EEA.For transfers from the EEA to countries not considered adequate by the European Commission,Supporter has ensured that adequate measures are in place,including by ensuring that the recipient is bound by the EU Standard Contractual Clauses,or has certified to the EU‐US Privacy Shield, or has implemented an EU‐approved code of conduct or certification, to protect personal information.You may obtain a copy of these measures by contacting our EU Data Protection Officer in accordance with the “Contacting Supporter” section below.
Data Subject Rights
If you would like to review,correct,update,restrict,or delete personal information that Supporter may have inits systems,or if you would like to request to receive an electronic copy of your personal information for purposes of transmitting it to an other company(to the extent these rights are provided to you by applicable law),you may contact Supporter as specified in the “Contacting Supporter”section.Supporter will respond to the request in accordance with applicable law.Please note,however,that certain personal information may be exempt from requests pursuant to applicable data protection laws,or other laws and regulations.
Supporter will retain your personal Information for as long as needed or permitted considering the purpose(s)for which it was obtained.The following criteria are used to determine the proper retention period:(i) the length of time Supporter has an ongoing relationship with you;(ii)whether there is a legal obligation to which Supporter or its affiliates are subject;and(iii) whether retention is advisable in light of Supporter’s legal position(such as in regard to applicable statutes of limitations,litigation,or regulatory investigations).
The Supporter can be contacted as specified below:
You may also contact the Data Protection Officer responsible for the relevant country or region,if applicable,at email@example.com.Incase of contacting the Data Protection Officer,information such as country location,as well as clinical trial number/name should be included to allow the request to be managed appropriately.
Lodging a Complaint with a Regulator
You may lodge a complaint with a supervisory authority competent for your country or region.Contact information can be located here: http://ec.europa.eu/justice/data‐protection/article‐29/structure/data‐protection‐authorities/index_en.htm
The EU General Data Protection Regulation ("GDPR") came into force across the European Union on May 25, 2018 and brings with it the most significant changes to data protection law in two decades.
Based on privacy by design and taking a risk-based approach, the GDPR has been designed to meet the requirements of the digital age.
The 21st Century brings with it broader use of technology, new definitions of what constitutes personal data, and a vast increase in cross-border processing. The new Regulation aims to standardize data protection laws and processing across the EU; affording individuals stronger, more consistent rights to access and control their personal information.
TurboRegs™/Study Budget Pro™'s registered office is at 102 Christopher Columbus Dr., Apt 909, Jersey City, NJ 07302. We are registered on the Information Commissioner's Office Register; registration number ZA535069, and act as the data controller when processing your data. Our designated Data Protection Officer/Appointed Person is Swadesh Sharma, who can be contacted at firstname.lastname@example.org or email@example.com .
TurboRegs™/Study Budget Pro™ (TR™/SBP™) is committed to ensuring the security and protection of the personal information that we process, and to provide a compliant and consistent approach to data protection.
We have always had a robust and effective data protection program in place which complies with existing law and abides by the data protection principles. However, we recognize our obligations to meet the demands of the GDPR and the UK Data Protection Act 2018. Our preparation and delivered objectives for GDPR compliance have been summarized in this statement and include the development and implementation of new data protection roles, SOPs, policies, procedures, controls and measures to ensure maximum and ongoing compliance.
TR™/SBP™ has a consistent level of data protection and security across our organization and has implemented the following GDPR SOPs and Processes:
Information Audit Process - company-wide information audit to identify and assess what personal information we hold, where it comes from, how and why it is processed and if and to whom it is disclosed.
Policies & Procedure SOPs - data protection policies and procedures to meet the requirements and standards of the GDPR and any relevant data protection laws, including: -
Data Protection - our main policy and procedure SOP for data protection has been overhauled to meet the standards and requirements of the GDPR. Accountability and governance measures are in place to ensure that we understand and adequately disseminate and evidence our obligations and responsibilities; with a dedicated focus on privacy by design and the rights of individuals.
Data Retention & Erasure - we have an updated retention SOP and schedule to ensure that we meet the 'data minimization' and 'storage limitation' principles and that personal information is stored, archived and destroyed compliantly and ethically. We have dedicated erasure procedures in place to meet the new 'Right to Erasure' obligation and are aware of when this and other data subject's rights apply; along with any exemptions, response timeframes and notification responsibilities.
Data Breaches - our data breach procedures SOP ensure that we have safeguards and measures in place to identify, assess, investigate and report any personal data breach within 72 hours. Our procedures are robust and have been disseminated to all employees, making them aware of the reporting lines and steps to follow.
International Data Transfers & Third-Party Disclosures - Currently not applicable, however, where TR™/SBP™ stores or transfers personal information outside the EU, we will have robust procedures and safeguarding measures in place to secure, encrypt and maintain the integrity of the data. Our SOP include a continual review of the countries with sufficient adequacy decisions, as well as provisions for binding corporate rules; standard data protection clauses or approved codes of conduct for those countries without. We carry out strict due diligence checks with all recipients of personal data to assess and verify that they have appropriate safeguards in place to protect the information, ensure enforceable data subject rights and have effective legal remedies for data subjects where applicable.
Subject Access Request (SAR) - TR™/SBP™ does not capture, store or process any patient level data.
Legal Basis for Processing - all processing activities are reviewed to identify the legal basis for processing and ensuring that each basis is appropriate for the activity it relates to. Where applicable, we also maintain records of our processing activities, ensuring that our obligations under Article 30 of the GDPR and Schedule 1 of the Data Protection Bill are met.
Privacy Notice/Policy - our Privacy Notice(s) to comply with the GDPR, ensuring that all individuals whose personal information we process have been informed of why we need it, how it is used, what their rights are, who the information is disclosed to and what safeguarding measures are in place to protect their information.
Obtaining Consent - our consent mechanisms for obtaining personal data, ensuring that individuals understand what they are providing, why and how we use it and giving clear, defined ways to consent to us processing their information. We have developed stringent processes for recording consent, making sure that we can evidence an affirmative opt-in, along with time and date records; and an easy to see and access way to withdraw consent at any time.
Data Protection Impact Assessments (DPIA) - where we process personal information that is considered high risk, we have developed stringent procedures and assessment templates for carrying out impact assessments that comply fully with the GDPR’s Article 35 requirements. We have implemented documentation processes that record each assessment, allow us to rate the risk posed by the processing activity and implement mitigating measures to reduce the risk posed to the data subject(s).
Processor Agreements - where we use any third-party to process personal information on our behalf (i.e. Payroll, Recruitment, hosting et cetera.), we have compliant Processor Agreements and due diligence procedures for ensuring that they (as well as we), meet and understand their/our GDPR obligations. These measures include initial and ongoing reviews of the service provided, the necessity of the processing activity, the technical and organizational measures in place and compliance with the GDPR.
In addition to the SOPs and procedures mentioned above that ensure individuals can enforce their data protection rights, we provide easy to access information via our website: PENDING LINK of an individual’s right to access any personal information that TR™/SBP™ processes about them and to request information about:
What personal data we hold about them
The purposes of the processing
The categories of personal data concerned
The recipients to whom the personal data has/will be disclosed
How long we intend to store your personal data for
If we did not collect the data directly from them, information about the source
The right to have incomplete or inaccurate data about them corrected or completed and the process for requesting this
The right to request erasure of personal data (where applicable) or to restrict processing in accordance with data protection laws, as well as to object to any direct marketing from us and to be informed about any automated decision-making that we use
The right to lodge a complaint or seek judicial remedy and who to contact in such instances
Information Security & Technical and Organizational Measures TR™/SBP™ takes the privacy and security of individuals and their personal information very seriously and take every reasonable measure and precaution to protect and secure the personal data that we process. We have robust information security policies and procedures in place to protect personal information from unauthorized access, alteration, disclosure or destruction and have several layers of security measures, including: - Encryption of DATA in transit and at rest, access controls, password policy, pseudonymization, 2-factor authentication
TR™/SBP™ have designated Swadesh Sharma as our DPO and have appointed a data privacy team to enforce compliance with the data protection regulation. The team is responsible for promoting awareness of the GDPR across the organization, enforcing compliance, identifying any gap areas and implementing the new policies, procedures and measures.